Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ryo Koizumi

Showing results (11-20 of 12) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 12 results.
Annals of the Rheumatic Diseases|July 4, 2024
Efficacy and safety of first-line biological DMARDs in rheumatoid arthritis patients with chronic kidney diseaseYusuke Yoshimura, Masayuki Yamanouchi, Hiroki Mizuno, et al.
Rheumatology (Oxford, England)|January 25, 2025
Efficacy and safety of first-line targeted synthetic DMARDs in rheumatoid arthritis patients with chronic kidney diseaseYusuke Yoshimura, Masayuki Yamanouchi, Ryo Koizumi, et al.
Pageof 2

Showing results (11-20 of 12) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 12 results.
Annals of the Rheumatic Diseases|July 4, 2024
Efficacy and safety of first-line biological DMARDs in rheumatoid arthritis patients with chronic kidney diseaseYusuke Yoshimura, Masayuki Yamanouchi, Hiroki Mizuno, et al.
Rheumatology (Oxford, England)|January 25, 2025
Efficacy and safety of first-line targeted synthetic DMARDs in rheumatoid arthritis patients with chronic kidney diseaseYusuke Yoshimura, Masayuki Yamanouchi, Ryo Koizumi, et al.
Pageof 2